Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
7.80
-0.04 (-0.51%)
At close: Dec 5, 2025, 4:00 PM EST
7.65
-0.15 (-1.92%)
After-hours: Dec 5, 2025, 6:00 PM EST
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $341.61 million as of December 5, 2025. Its market cap has increased by 93.94% in one year.
Market Cap
341.61M
Enterprise Value
175.50M
1-Year Change
93.94%
Ranking
Category
Stock Price
$7.80
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $341.61M, a decrease of -61.96%. That is a compound annual growth rate of -41.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 341.61M | 111.57% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |